Advances in Diagnostic Imaging for Cardiac Sarcoidosis.
Osamu ManabeNoriko Oyama-ManabeTadao AikawaSatonori TsunetaNagara TamakiPublished in: Journal of clinical medicine (2021)
Sarcoidosis is a systemic granulomatous disease of unknown etiology, and its clinical presentation depends on the affected organ. Cardiac sarcoidosis (CS) is one of the leading causes of death among patients with sarcoidosis. The clinical manifestations of CS are heterogeneous, and range from asymptomatic to life-threatening arrhythmias and progressive heart failure due to the extent and location of granulomatous inflammation in the myocardium. Advances in imaging techniques have played a pivotal role in the evaluation of CS because histological diagnoses obtained by myocardial biopsy tend to have lower sensitivity. The diagnosis of CS is challenging, and several approaches, notably those using positron emission tomography and cardiac magnetic resonance imaging (MRI), have been reported. Delayed-enhanced computed tomography (CT) may also be used for diagnosing CS in patients with MRI-incompatible devices and allows acceptable evaluation of myocardial hyperenhancement in such patients. This article reviews the advances in imaging techniques for the evaluation of CS.
Keyphrases
- computed tomography
- positron emission tomography
- magnetic resonance imaging
- contrast enhanced
- left ventricular
- high resolution
- heart failure
- end stage renal disease
- dual energy
- diffusion weighted imaging
- image quality
- ejection fraction
- chronic kidney disease
- prognostic factors
- magnetic resonance
- oxidative stress
- systematic review
- multiple sclerosis
- cardiac resynchronization therapy
- pet ct
- peritoneal dialysis
- rheumatoid arthritis
- atrial fibrillation
- ultrasound guided
- photodynamic therapy
- patient reported outcomes
- drug induced
- pet imaging
- idiopathic pulmonary fibrosis